A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ACM / aclacinomycin

[Related PubMed/MEDLINE]
Total Number of Papers: 33
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ACM  (>> Co-occurring Abbreviation)
Long Form:   aclacinomycin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a]. ATO, CI
2016 Self-assembled albumin nanoparticles as a nanocarrier for aclacinomycin A. AOA, HSA, MALDI-TOF, TCEP
2013 High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer. EGFR, ER, HTS, NCI, NSCLC, RTKs
2004 [Study on the relationship between the inhibitors of apoptosis proteins and the apoptosis of myelodysplastic syndrome cell line cells induced by aclacinomycin in vitro]. cIAPs, MDS, RT-PCR, TUNEL
2002 Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation. ---
1997 Enhanced functional capacity of the peritoneal macrophages as antigen presenting cells after aclacinomycin treatment in mice. ---
1996 Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells. DOX, EpoR, HEM, PBGD
1995 Interaction between intercalation type anticancer drugs and DNA studied by ultraviolet resonance Raman spectroscopy. ADM, UVRRS
1994 Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. DOX
10  1993 Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells. ---
11  1992 Thermodynamics of the anthracycline-nuclei interactions in drug-resistant and drug-sensitive K562 cells. ADR, THP-ADR
12  1991 Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells. EPO
13  1990 Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei. ADR, DNR, THP-ADR
14  1990 Enhanced production of interleukin 1 by mouse peritoneal macrophages after aclacinomycin administration. ---
15  1990 Phospholipase A2, an in vivo immunomodulator. AA, CL, NDGA, PLA2, SOD, TDM
16  1990 [Increase of proliferative and cytotoxic responses to alloantigenic stimulation of mouse spleen cells treated with aclacinomycin]. ---
17  1989 Effect of aclacinomycin on lipid peroxide levels in tissues of mice. ADR, NADPH
18  1989 Enhanced activity of peritoneal cells after aclacinomycin injection: effect of pretreatment with superoxide dismutase on aclacinomycin-induced cytological alterations and antitumoral activity. SOD
19  1989 [Balloon occluded arterial infusion (BOAI) therapy in patients with progressive cervical carcinoma]. BLM, BOAI
20  1988 Enhanced activity of murine peritoneal cells after aclacinomycin injection: characteristics of the enhanced respiratory burst. CL, PC, PG
21  1987 Enhanced activity of mouse peritoneal cells after aclacinomycin administration. ---
22  1987 Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells. DMSO, NBT, NSE, RA, TPA
23  1986 Enhancement of NK-cell activity in normal and tumor-bearing mice after administration of aclacinomycin. ---
24  1985 Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells. BL, MM
25  1985 Experimental studies on aclacinomycin. ADR
26  1984 Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs. ADM, CAM, DNR, DTR, eADM, EM, l-DNR, MTX, RBC, RBZ, THP-ADM
27  1983 In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line (HeLa). 5-FU, 6-MP, ACD, ACNU, ADM, HeLa, HU, MMC, MTX, PEP, VCR
28  1983 [Pilot studies with aclacinomycin in patients with breast cancer or gastrointestinal tumors]. PCW
29  1982 Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells. 4D-DNM, ADM, CMM, DNM, MCM, PYM
30  1981 Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells. ---
31  1980 Ultrastructural study of the cardiotoxicity and light-microscopic findings of the skin after treatment of golden hamsters with seven different anthracyclines. ADM, DNR, DTR, eADM, EM, LM, RBZ
32  1979 Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin. ADR, DTR
33  1979 [Ultrastructural study of cardiotoxicity and skin alterations in the golden hamster after treatment with 8 different anthracyclines]. ADM, ADMh, DNR, DTR, eADM, EM, LM, RBZ